Product Image

L-Carnitine

Pure Encapsulations
4.7
★ ★ ★ ★ ★
(15 ratings)
L-Carnitine 680 mg
Product Image
Score65
A focused L-carnitine L-tartrate serving with a high cost per estimated active gram. Elemental carnitine yield and branded purity are not stated is the main quality limitation.
How scoring works
Quantity:120 Capsule(s) • (60 servings)
Goals:
Cardiovascular Support

Score 65

A focused L-carnitine L-tartrate serving with a high cost per estimated active gram. Elemental carnitine yield and branded purity are not stated is the main quality limitation.
How scoring works
$97.00($1.61 per serving)
Pure Formulas
$ 97.00
Vitacost
$ 97.00
Report prices

Analysis

680 mg of compound of L-carnitine L-tartrate forms the core of the serving. The ingredient may support exercise or cardiovascular needs when carnitine support is relevant, but it is not a direct fat-loss shortcut.

The formula is best aligned with cardiovascular support. Benefits for energy or cognition depend on the specific form and the user’s baseline status.

The amount is clearly listed and a high cost per estimated active gram supports practical use. Elemental carnitine yield and branded purity are not stated prevents a stronger judgment of elemental yield, purity, and form-specific fit.

Who is it for
  • Adults seeking focused carnitine supplementation
  • People interested in cardiovascular support
  • Users who tolerate carnitine
Best for
  • Carnitine supplementation
  • Exercise-related support
  • Cardiovascular nutrient support

Pros

  • Clearly states the carnitine amount
  • Provides 680 mg of compound
  • Keeps the formula focused

Cons

  • Elemental carnitine yield and branded purity are not stated
  • Benefits depend on individual need
  • May require more than one serving for higher intake

Warnings

  • L-carnitine may cause nausea, diarrhea, cramps, or a fishy body odor in sensitive users.
  • Carnitine can interact with warfarin and may require closer anticoagulation monitoring.
  • People with seizure disorders should review carnitine use because it may worsen seizure risk in susceptible users.

Nutrient quality

77 High impact

A specific tartrate form provides a credible and focused carnitine source. Low estimated active yield limits dose depth.

.

Ingredient transparency

78 High impact

The chemical form and compound weight are clearly listed without a hidden blend. Elemental yield, full directions, and complete excipients remain unavailable.

.

Customer satisfaction

57 Moderate impact

The supplied aggregate satisfaction signal is favorable and has some support from its response volume. Specific experience details are absent, so complaint patterns and purpose fit cannot be confirmed.

.

Value for money

39 Lower impact

Some core tartrate formula value is present. High serving positioning and major formulation weaknesses make the product uncompetitive.

.
Report analysis

Goals

Cardiovascular Support
Impact
High effect
C+ Goal FitC Strength of SupportD CoverageA Formula Quality
L-Carnitine · 680 mg

L-carnitine tartrate supports fatty-acid transport and may contribute to cardiac energy. The estimated active carnitine yield is below a full targeted amount, limiting depth.

The tartrate form is clearly identified, but only compound weight is given. No lipid, nitric-oxide, rhythm, or antioxidant ingredient broadens the formula.

Study evidence
L-Carnitine Supportive 73 studies

Ingredients

IngredientAmount per serving
L-Carnitine (L-Carnitine L-Tartrate)
680 mg
Gluten Free Adults 18–50
Report overview
B- Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

L-carnitine tartrate is strongly aligned with fitness recovery, but its estimated elemental yield is below a full maintenance dose. The label lists compound weight without elemental yield and does not identify a branded purity source. A high cost per estimated gram makes it a weak value.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis.
    Shang R; Sun Z; Li H · BMC cardiovascular disorders · 2015
    Meta-analysis3,108 participants5 studies pooledCardiovascular Support forL-Carnitine
  2. The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia.
    Shahidi M; Hashemi SR; Fattahi N; Roshani D; Vahedi S; Sharifi P; Moradveisi B · Journal of pediatric hematology/oncology · 2020
    Randomized trial60 participantsCardiovascular Support forL-Carnitine
  3. The Effects of L-Carnitine Supplementation on Serum Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Fathizadeh H; Milajerdi A; Reiner Ž; Kolahdooz F; Chamani M; Amirani E; Asemi Z · Current pharmaceutical design · 2020
    Meta-analysis67 studies pooledCardiovascular Support forL-Carnitine
  4. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
    Koeth RA; Wang Z; Levison BS; Buffa JA; Org E; Sheehy BT; Britt EB; Fu X; Wu Y; Li L; Smith JD; DiDonato JA; Chen J; Li H; Wu GD; Lewis JD; Warrier M; Brown JM; Krauss RM; Tang WH; Bushman FD; Lusis AJ; Hazen SL · Nature medicine · 2013
    Other2,595 participantsCardiovascular Support forL-Carnitine
  5. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.
    Malaguarnera M; Vacante M; Avitabile T; Malaguarnera M; Cammalleri L; Motta M · The American journal of clinical nutrition · 2009
    Randomized trial81 participantsCardiovascular Support forL-Carnitine
  6. L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Choi M; Park S; Lee M · Nutrients · 2021
    Meta-analysis9 studies pooledCardiovascular Support forL-Carnitine
  7. The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.
    Mirrafiei A; Jayedi A; Shab-Bidar S · Clinical therapeutics · 2024
    Meta-analysis2,041 participants21 studies pooledCardiovascular Support forL-Carnitine
  8. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F · Atherosclerosis · 2007
    Randomized trial52 participantsCardiovascular Support forL-Carnitine